Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) Income from Continuing Operations: 2022-2023

Historic Income from Continuing Operations for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -$5.2 million.

  • Mainz Biomed N.V's Income from Continuing Operations rose 36.70% to -$5.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.3 million, marking a year-over-year increase of 0.35%. This contributed to the annual value of -$21.7 million for FY2024, which is 17.66% up from last year.
  • As of Q4 2023, Mainz Biomed N.V's Income from Continuing Operations stood at -$5.2 million, which was up 17.72% from -$6.3 million recorded in Q3 2023.
  • In the past 5 years, Mainz Biomed N.V's Income from Continuing Operations registered a high of -$5.2 million during Q4 2023, and its lowest value of -$8.3 million during Q2 2023.
  • Its 2-year average for Income from Continuing Operations is -$6.6 million, with a median of -$6.4 million in 2023.
  • The largest annual percentage gain for Mainz Biomed N.V's Income from Continuing Operations in the last 5 years was 36.70% (2023), contrasted with its biggest fall of 18.92% (2023).
  • Over the past 2 years, Mainz Biomed N.V's Income from Continuing Operations (Quarterly) stood at -$8.2 million in 2022, then spiked by 36.70% to -$5.2 million in 2023.
  • Its Income from Continuing Operations stands at -$5.2 million for Q4 2023, versus -$6.3 million for Q3 2023 and -$8.3 million for Q2 2023.